Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Weight Loss × Mirtazapine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Weight Loss 1 Pancreatic Neoplasms 1 Malnutrition 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Body Weight 1

Interventions

anamorelin 2 Megestrol Acetate 2 Sugars 1 Palonosetron 1 Nutrition Assessment 1 Mirtazapine 1 Metformin 1 Melatonin 1 Liraglutide 1 Flurandrenolone 1 Exenatide 1 Endoscopy, Digestive System 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00832520 2018-04-10

Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight

New Mexico Cancer Research Alliance

Phase 2 Terminated

13 enrolled 4 charts

Body Weight, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡